共 60 条
[1]
Chan H.C.S., Shan H., Dahoun T., Vogel H., Yuan S., Advancing drug discovery via artificial intelligence, Trends Pharmacol. Sci, 40, 8, pp. 592-604, (2019)
[2]
Cruciger O., Schildhauer T.A., Meindl R.C., Tegenthoff M., Schwenkreis P., Citak M., Aach M., Impact of locomotion training with a neurologic controlled hybrid assistive limb (HAL) exoskeleton on neuropathic pain and health related quality of life (HRQoL) in chronic SCI: a case study, Disabil. Rehabil. Assist. Technol, 11, 6, pp. 529-534, (2016)
[3]
Diaz O., Dalton J.A.R., Giraldo J., Artificial intelligence: a novel approach for drug discovery, Trends Pharmacol. Sci, 40, 8, pp. 550-551, (2019)
[4]
Habermann J., Psychological Impacts of COVID-19 and Preventive Strategies: A Review, (2021)
[5]
Harrer S., Shah P., Antony B., Hu J., Artificial intelligence for clinical trial design, Trends Pharmacol. Sci, 40, 8, pp. 577-591, (2019)
[6]
Holzinger A., Biemann C., Pattichis C.S., Kell D.B., What Do We Need to Build Explainable AI Systems for the Medical Domain, (2017)
[7]
Hummel P., Braun M., Just data? Solidarity and justice in data-driven medicine, Life Sci., Soc. Policy, 16, 1, pp. 1-18, (2020)
[8]
Schmidt-Erfurth U., Bogunovic H., Sadeghipour A., Et al., Machine learning to analyze the prognostic value of current imaging biomarkers in neovascular age-related macular degeneration, Opthamol. Retina, 2, pp. 24-30, (2018)
[9]
Lee S.I., Celik S., Logsdon B.A., Et al., A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia, Nat. Commun, 9, (2018)
[10]
Sordo M., Introduction to neural networks in healthcare, Openclin., (2002)